We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Exhibits IVD Testing Solutions for POC and Critical Care at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)
Image: EMS Stat is a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT (Photo courtesy of Nova)

Nova Biomedical (Waltham, MA, USA) is exhibiting its IVD testing solutions for point-of-care (POC) and critical care in the hospital and clinical areas at MEDICA 2022. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care.

On display at Nova’s booth is Allegro, a fast and compact POC capillary blood analyzer that offers a clinically important menu of 12 measured and individually selectable tests, as well as six calculated tests. All tests are measured with ready-to-use disposable cassettes or test strips and can be easily performed by non-technical personnel. Allegro uses a very small capillary blood drop for all blood tests, eliminating the need for venipuncture or a trained phlebotomist. With cartridge test times of six to nine minutes and the ability to measure two cartridges simultaneously, Allegro delivers fast results. Results are available during the patient visit - not after - making the patient-physician conversation more effective, reducing calls, letters and follow-up visits, and improving patient adherence to care recommendations.

Nova is also demonstrating EMS Stat, a portable system for use in the emergency department to determine GLU, KET, LAC, Hb and HCT. Stat EMS measures glucose, ketone bodies, lactate, hematocrit and hemoglobin from a capillary blood drop. Results are available within seconds, depending on the test. Combining disposable biosensor technology with portable electronics, Stat EMS provides simple, fast and accurate testing in the field. Stat EMS provides an important test menu for immediate patient assessment and faster, more effective emergency treatment. Stat EMS also assists in rapid triage and determining appropriate transport location for patients with trauma, sepsis or other special needs.

In addition, Nova is presenting the StatStrip Hemoglobin and Hematocrit Measurement System (StatStrip Hb/Hct), the only POC system that provides anemia screening and monitoring with measured rather than calculated Hb and Hct values. This important breakthrough is possible thanks to new, patented electrochemical technologies developed by Nova. Together with tiny capillary samples (1.6 µl) and results in 40 seconds, the StatStrip Hb/Hct improves clinical decision making at the POC. At MEDICA 2022, Nova is also showcasing BioProfile FLEX2 that combines Nova's breakthrough MicroSensor Card technology with optical sensing and freezing point osmometry to create an automated and comprehensive cell culture analyzer that eliminates chemical sensor maintenance, increases analyzer speed and reduces sample volume.

Related Links:
Nova Biomedical 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.